Results 91 to 100 of about 8,704 (178)

Drug-Resistant Sinus Tachycardia as a Dose-Dependent Side Effect of Spironolactone: A Case Report and Review of the Literature. [PDF]

Clin Case Rep
Abdi Z, Chenaghlou M, Rezabakhsh A, Hooshmand Gharabagh L.   +3 more
europepmc   +1 more source

Evaluation of Changes in Optical Coherence Tomography (OCT) Biomarkers After Oral Eplerenone Therapy in Chronic Central Serous Chorioretinopathy and Their Correlation to Functional Visual Outcome. [PDF]

Cureus
Mishra P, Moharana B, Palanisamy S, Nayak B, Panda BB, Sahu SK, Parija S.   +6 more
europepmc   +1 more source

Finerenone in mildly reduced or preserved ejection fraction and chronic kidney disease: a narrative review. [PDF]

Egypt Heart J
Faheem MSB, Qurat Ul Ain H, Rauf A, Faheem Q, Najmi OEM.   +4 more
europepmc   +1 more source

Oral Eplerenone for Exudative Retinal Detachment Secondary to Central Serous Chorioretinopathy: A Case Report. [PDF]

Cureus
Paliwal S, Upadhaya P, Thakar S.
europepmc   +1 more source

Emerging roles for endothelial mineralocorticoid receptor in disease pathogenesis: potential new indications for mineralocorticoid receptor antagonism. [PDF]

Curr Opin Physiol
An W, Jaffe IZ.
europepmc   +1 more source

EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial. [PDF]

Trials
Simon A, Girerd N, Jaisser F, Bozec E, Lepage X, Mercklé L, Rossignol P, Frimat L, Girerd S.   +8 more
europepmc   +1 more source

Cardiac response to chronic restraint stress involves mineralocorticoid receptors in male Sprague-Dawley rats. [PDF]

Physiol Rep
Sztechman D, Zera T, Czarzasta K, Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A.   +4 more
europepmc   +1 more source

Central Serous Chorioretinopathy: Etiology, Diagnosis, and Treatment. [PDF]

Dtsch Arztebl Int
Lange C, Lahmann C, Pauleikhoff L.
europepmc   +1 more source

Eplerenone improves kidney function and cardiac performance in obese male mice. [PDF]

Diabet Med
Banah AK, Qi B, Koh R, Lawlor A, Wang T, Musale V, Mains J, Murdoch CE, Kang L.   +8 more
europepmc   +1 more source

Nonsteroidal mineralocorticoid receptor antagonists and cardiovascular events in type 2 diabetes: a retrospective study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Chen YH, Fang YW, Chen MT, Liou HH, Tsai MH.   +4 more
europepmc   +1 more source